LMO3 (LIM domain only 3) is a transcriptional cofactor that regulates multiple developmental and metabolic processes through protein-protein interactions and transcriptional modulation. The protein functions as a nuclear transcriptional coactivator that enhances PPARγ activity and promotes cellular differentiation 1. In adipose tissue, LMO3 improves insulin sensitivity and mitochondrial oxidative capacity by increasing glucose uptake, GLUT4 translocation, and fatty acid oxidation through PPARγ/Ncoa1 pathways 1. During osteogenic differentiation, LMO3 acts as a positive regulator by activating PI3K/Akt signaling in human adipose-derived stem cells 2. The protein shows tissue-specific expression patterns and plays distinct roles in different cellular contexts 3. However, LMO3 also exhibits oncogenic properties, promoting cell proliferation and invasion in gastric cancer through Akt-mTOR and Akt-GSK3β signaling pathways 4. In neuroblastoma, LMO3 cooperates with HEN2 to enhance tumor growth and is associated with poor prognosis 5. Additionally, LMO3 expression affects neuronal differentiation processes and is regulated by miR-101 through promoter methylation mechanisms 6. These diverse functions highlight LMO3's dual role as both a metabolic regulator and potential oncogene.